US 8999934
Treatment of astrocytes-tumor cells inhibitors of endothelin receptors
granted A61KA61K31/337A61K31/4188
Quick answer
US patent 8999934 (Treatment of astrocytes-tumor cells inhibitors of endothelin receptors) held by The Board of Regents of the University of Texas System expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/337, A61K31/4188, A61K31/495, A61K31/506